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Abstract
The purpose of the Emergency Medical Services Outcomes
Project (EMSOP) is to develop a foundation and framework
for out-of-hospital outcomes research. In prior work, this
group delineated the priority conditions, described concep-
tual models, suggested core and risk adjustment measures
potentially useful to emergency medical services research,
and summarized out-of-hospital pain measurement. In this
fifth article in the EMSOP series, the authors recommend
specific risk-adjustment measures and outcome measures
for use in out-of-hospital research on patients presenting
with respiratory distress. The methodology included sys-
tematic literature searches and a structured review by an
expert panel. The EMSOP group recommends use of pulse
oximetry, peak expiratory flow rate, and the visual analog
dyspnea scale as potential risk-adjustment measures and
outcome measures for out-of-hospital research in patients
with respiratory distress. Furthermore, using mortality as an
outcome measure is also recommended. Future research is
needed to alleviate the paucity of validated tools for out-of-
hospital outcomes research. Key words: respiratory distress;
outcomes; pulse oximetry; peak expiratory flow rate; visual
analog dyspnea scale; mortality; out-of-hospital research;
risk adjustment. ACADEMIC EMERGENCY MEDICINE
2004; 11:1074–1081.
This is the fifth article in a series reporting the results of
the work of the EmergencyMedical Services Outcomes
Project (EMSOP). EMSOP was a five-year project
funded by the National Highway Traffic Safety Ad-
ministrationwith the aims to identify 1) conditions that
take precedence in emergency medical services (EMS)
outcomes research, 2) risk-adjustment measures
(RAMs) for these priority conditions, and 3) outcome
measures (OMs) for these priority conditions. Prior
articles have described the initial investigators (RFM,
HGG, DWS), consultants (JSD, CGC, JLC, DRM, EJM,
PJO, IGS), expert panel members, general methods,
and priority conditions1; described conceptual mod-
els2; suggested core and risk-adjustment measures
potentially useful to EMS research3; and summarized
out-of-hospital pain measurement.4 In this article,
measures that can be used for risk adjustment and
outcomes evaluation for the out-of-hospital condition
of respiratory distress are identified and discussed.
In a prior article, out-of-hospital conditions were
rank-ordered by an expert panel based on condition
frequency and expert opinion of the potential impact
of EMS intervention on the outcome of that condi-
tion.1 The 42 individuals making up the expert panel
included 23 physicians and 19 career EMS profession-
als. Their names, affiliations, and rationale for in-
volvement are detailed in the prior work.1 In addition,
the experts ranked the relevance of outcome catego-
ries (death, discomfort, disability, disease, destitution,
and dissatisfaction) for each out-of-hospital condi-
tion.5,6 In this weighted priority ranking, respiratory
distress ranked second among conditions for adults
and third among conditions for children. An EMS
condition was defined as an illness, injury, or combi-
nation of signs and symptoms that cause EMS acti-
vation. Implicit in this definition is that a single
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EMS condition can encompass multiple diagnoses or
diseases. Several specific disease states fall under the
condition of respiratory distress, including but not
limited to asthma, chronic obstructive pulmonary
disease (COPD), and congestive heart failure (CHF).
This produces one of the major challenges in identi-
fying RAMs and OMs for EMS. This problem, how-
ever, is intrinsic to out-of-hospital care because
patients present in the field with conditions, not
diagnoses. Out-of-hospital care providers are, how-
ever, trained to make and act on condition assess-
ments, not diagnosis. Additionally, the ‘‘impurity’’
introduced by the necessary mixing or grouping of
multiple diagnoses in a ‘‘condition’’ has not prevented
meaningful outcomes research when care has been
taken to develop robust methods.7–13
METHODS
This study involved repeated explicit literature
searches followed by consensus group reviews.
Definition of Terms.
Risk-adjustment Measure. A RAM is a variable that
meaningfully reflects a patient’s characteristics and
clinical attributes or otherwise affects or confounds
a patient’s outcome in some way. RAM techniques
often may also serve as OMs, for example, blood
pressure measurements that are taken before (RAM)
and after (OM) an intervention, although the prein-
tervention technique would always be considered
a RAM and the postintervention technique an OM.
Previous work by the EMSOP group has described
a conceptual framework for risk adjustment and out-
comes evaluation in EMS research.2 Some RAMs will
be similar across conditions, and a standard set of
‘‘core’’ EMS RAMs has been described.3 Others are
explicit for specific conditions (e.g., Revised Trauma
Score). RAMs are essential ingredients for investiga-
tions that target the effectiveness of EMS interventions
related to dyspnea to minimize potentially confound-
ing factors.
Outcome Measure. An OM is a variable that mean-
ingfully reflects one or more of the outcome categories
of death, discomfort, disability (functional impair-
ment), disease, destitution (cost), and dissatisfaction
(satisfaction).5,6 Some OMs may be applicable across
conditions, whereas others are specific to a particular
condition. Ideal OMs for out-of-hospital use would be
easily and quickly applied, be applicable to all ages,
and not require prolonged training or expensive,
complicated, or bulky equipment.
For this study, RAMs and OMs were identified by
a systematic literature search and a structured review
of original research articles pertaining to each poten-
tial measure. Measures were evaluated by a method
previously used to develop OMs in physical therapy
by the Canadian Physiotherapy Association.14 After
evaluation, each measure was discussed and a deci-
sion made to recommend or discard the measure. The
methodology of the search and reviews, findings, and
recommended measures were presented to and re-
viewed by a consultant group (JSD, CGC, JLC, DRM,
EJM, PJO, IGS) and are shown in Figure 1.
Phase One.
Step 1: Literature Review Strategy. The initial phase
consisted of a MEDLINE search of English-language
articles from 1986 to 1996 by the primary investigators
(RFM,HGG,DWS) using theOvid (Ovid Technologies)
search engine. An initial set of references was devel-
oped by combining the search for respiratory distress
with a search for RAMs and OMs. MeSH search terms
chosen by the investigators are shown in Figure 1.
Step 2: References Limited. This initial set of refer-
ences was then limited to English-language articles
that pertained to human subjects and were published
in Abridged Index Medicus (AIM) journals. This
created a final reference set of 2,836 references. The
titles were reviewed by the investigators in a struc-
tured manner. References that focused on develop-
ment or evaluation of a measure were included for
further review. Studies that included the measures in
clinical trials but did not specifically evaluate RAMs
or OMs were not included. A study was included for
further review if any single investigator chose it. A
unanimous rejection of a title was required for the
reference to be eliminated from further review. A total
of 497 titles were selected for further review.
Step 3: Abstracts Reviewed. Abstracts of the selected
references were obtained and reviewed. Each abstract
was reviewed by all of the investigators. Papers not
evaluating the feasibility, reliability, or validity of
RAMs or OMs were excluded from the next review.
An abstract required unanimous rejection by the
investigators to be excluded from further evaluation.
A total of 175 abstracts were selected for further
review. For each abstract selected, the full-length
article was obtained.
Step 4: Articles Reviewed and Sorted. Examination of
these full-length papers resulted in 75 studies focused
on the development or evaluation of a RAM or OM.
Articles were then sorted into groups based on the
measure addressed (e.g., dyspnea scales or measure-
ments of pulmonary function). An implicit structured
review of each group of articles pertaining to each
measure was conducted by a single investigator using
the guidelines from ‘‘Physical Rehabilitation Outcome
Measures’’ published by the Canadian Physiotherapy
Association.14 The attributes evaluated for each mea-
sure included time taken to complete the measure,
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cost and training, scaling, reliability, and validity.
These guidelines were modified to include feasibility
of use in the out-of-hospital setting. Reviews were
conducted independently and documented in a stan-
dardized fashion. References listed in the articles that
pertained to the development of RAMs or OMs were
obtained and reviewed.
Step 5: Group Presentations and Consensus. The
written individual reviewswere presented to the entire
group of investigators and consultants. Each investi-
gator orally presented the results of his or her review
following the modified Canadian Physiotherapy As-
sociation guidelines and made recommendations
regarding the appropriateness of the measure for out-
Figure 1. Methodology for identifying risk-adjustment measures (RAMs) and outcome measures (OMs). CPA = Canadian Physio-
therapy Association.
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of-hospital outcomes research. After each presentation,
a discussion ensued that resulted in a decision to
recommend or reject the measure. A decision to reject
or accept eachmeasurewasmade based on unanimous
agreement among the investigators and consultants.
Phase Two: Repeat Search and Review. Following
the acceptance of each measure, another structured
literature search was performed. A MEDLINE search
using the Ovid search engine was performed of
English-language articles from 1959 to 1996 inclusive
using the title of the measure as a search term and
searching in the title, abstract, and body of an article
to find all manuscripts containing that measure. A
single investigator reviewed the title list generated
from this search, and titles dealing with the develop-
ment or evaluation of the measure were selected. A
single investigator reviewed abstracts of these articles.
Finally, a careful review of all article references was
performed, appropriate additional references were
identified, and the full-length articles were reviewed.
Results of this review were then discussed with the
other investigators and a consensus reached on meas-
ures to recommend. Findings from all newly found
articles were also discussed. No new measures were
identified. These findings were presented to the pro-
ject consultants. The consultants unanimously sup-
ported the recommendations and had no suggestions
for additional measures.
Phase Three: Repeat Search and Review. A second
structured literature search was performed in October
2003 by the investigators (SMK, DWS, RFM). A MED-
LINE search using the Ovid search engine was
performed of articles from 1997 to October 2003
inclusive combining the original MeSH search terms
with the RAMs and OMs from the initial search as
shown in Figure 1. This search yielded a set of
references that were limited to English language,
human subjects, and publication in AIM journals.
This created a reference set of 215 references. The titles
were reviewed in the same structured manner as the
initial review. Eleven titles were selected for further
review. Abstracts of the selected references were
reviewed. Reports not evaluating the feasibility, re-
liability, or validity of RAMs or OMs were excluded.
Three abstracts were selected for full-article review.
Examination of these articles with the same structured
review conducted in Phase One resulted in the re-
jection of all three RAMs after group discussion.
RESULTS
The RAMs and OMs identified are listed in Table 1. Of
those identified and evaluated, only four will be
recommended for use in out-of-hospital research
and care of patients with respiratory distress. Those
rejected failed, under structured review and consen-
sus panel discussion, to be measures to be recom-
mended for out-of-hospital use.
Peak Expiratory Flow Rate. Peak expiratory flow
rate (PEFR) is one of a group of forced expiratory flow
measures taken at the point of total lung capacity or at
the point of maximal inspiration.15,16 Wright and
McKerrow first described the measurement of the
PEFR and the instrument used to obtain the measure-
ment in 1959.17 The PEFR is primarily an index of
obstruction in large airways. Mechanisms affecting
the PEFR are the various causes of airway obstruction
such as bronchomotor tone, tracheal obstruction,
impaired mucus clearance, and modest effects of
altitude.18–23 The use of the PEFR to monitor both
in-hospital and out-of-hospital patients with asthma
has been widely studied.19,24–26 Its use in the treat-
ment and evaluation of COPD has also been recom-
mended.24 Studies in patients with CHF have found
only mild decreases in PEFR in stable patients but
higher decreases in patients with severe symptoms of
CHF.27
Since the first article by Wright and McKerrow,
various other instruments have been developed to
measure the PEFR. These have been inexpensive
portable devices that have been calibrated using the
Wright flow meter as a standard.28–35 A device that is
frequently used today in the United States is the mini-
Wright peak flow meter.28–31,34–36 Children as young
as 4 years of age can be taught to use portable devices
to measure PEFR.37,38
The validity of the PEFR has been measured using
the forced expiratory volume in 1 second (FEV1) as
a criterion standard. In general, the PEFR correlates
well with FEV1.
39–43 Di Maria et al. showed correla-
tion between the PEFR and FEV1 ranging from 0.84 to
TABLE 1. Outcome of Measures Reviewed
Measures Identified
and Rejected Measures Accepted
Fischl Index (for asthma
severity) Pulse oximetry
Fischl Index: Weiss
modification Peak expiratory flow rate














Group Asthma Short Form
Rhinoconjunctivitis and
Asthma Symptom Score
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0.93.44 Studies conducted in emergency departments
(EDs) have found correlations ranging from 0.77 to
0.83 in asthma and 0.69 in COPD.45 Because of these
studies, the authors believe that the PEFR has been
shown to be feasible for the out-of-hospital setting.
Pulse Oximetry. Oxygen saturation represents the
percent saturation of available bound hemoglobin.
The pulse oximeter (SpO2) is a common noninvasive
device that represents a combination of oximetry and
plethysmographic technologies and measures oxy-
gen saturation.46,47
Comparisons of pulse oximetry with arterial blood
gases have shown high accuracy and agreement in
both adults and children.48–51 Commonly used pulse
oximeters are accurate within 62% (SD) from 70% to
100% saturation and 63% (SD) from 50% to 70%
saturation, with no specified accuracy below 50%
saturation.52 Evaluations of the accuracy and feasibil-
ity of pulse oximetry in the ED and out-of-hospital
setting have also been conducted. These have found
the devices to be accurate and their use very feasi-
ble.53–55 Because of this broad body of literature, the
authors believe that pulse oximetry has been shown to
be feasible for the out-of-hospital setting.
Several potential problems with the use of pulse
oximetry have implications for out-of-hospital use.
The presence of carboxyhemoglobin or methemoglo-
bin may result in inaccuracies.56 Ambient light, dark
skin, nail polish, and motion artifact can all affect the
accuracy of the measurement.57,58 Severe anemia may
affect the accuracy of the measurement if the oxygen
saturation is \75%. Furthermore, pulse oximetry
requires a pulsating vascular bed. Therefore, it may
be inaccurate in low flow states.58
Visual Analog Dyspnea Scale. Dyspnea can be
defined as the unpleasant sensation of labored or
difficult breathing and is synonymous with the term
‘‘shortness of breath.’’ The visual analog dyspnea
scale (VADS) is a self-reported measure of shortness
of breath. The patient is asked to indicate the degree
of shortness of breath experienced by marking the line
at the level indicating his or her level of discomfort.
One end represents ‘‘not at all breathless’’ and the
other end ‘‘worst possible breathlessness.’’ Aitken
was the first to show that a VADS was a valid measure
of dyspnea using a horizontally oriented scale.59 Gift
and colleagues improved on Aitken’s work by reor-
ienting the scale to a vertical line and testing the scale
in clinical situations using patients with asthma and
patients with COPD.60,61 This reorientation facilitated
ease and understanding of use by patients. Investiga-
tions have shown that the VADS is valid for children
with fully developed communication skills.62
The VADS has been validated in healthy volunteers,
patients with asthma, patients with COPD, and pa-
tients with cancer, with a variety of underlying causes
of dyspnea.59–64 Correlation between the VADS and
PEFR is good, ranging from 0.72 to 0.85.59 The
test–retest reliability of the VADS has been shown to
be high.64 Similar to potential challenges with the out-
of-hospital use of the visual analog scale for pain,4 the
severity of a patient’s dyspnea and interventions in
the out-of-hospital setting may prevent optimal use of
the VADS. The VADS should be studied in the out-of-
hospital setting to ensure its feasibility for use, but the
investigators recommend it nonetheless as a proposed
measure.
Mortality. Unlike all other measures discussed thus
far, which can function as either a RAM or an OM,
mortality is the only recommended measure that is
exclusively an OM. Although long-term mortality is
significantly more important, short-term mortality
(alive or dead on arrival at the hospital) is easily
obtainable by out-of-hospital personnel and an ap-
propriate OM for the out-of-hospital unit of service.
Accessing mortality information after arrival at the
hospital requires data linkage.
Disability, Satisfaction, and Cost Outcomes. No
specific OMs proven to be applicable to the condition
of respiratory distress in the out-of-hospital setting
were found on review of the literature on disability
(functional outcomes), patient satisfaction, or cost–
effectiveness. Review of the references showed either
disease-specific measures that had been developed to
evaluate changes in chronic conditions over long
periods of time or generic health status measures that
had never been evaluated for assessing care rendered
in the field. Because of this, we will not recommend
any of these OMs for application in out-of-hospital
research.
DISCUSSION
We recommend four measures that hold significant
promise as priority RAMs and OMs for current use:
PEFR, pulse oximetry, VADS, and mortality. The first
three measures can be used as both RAMs and OMs.
Core RAMs discussed in EMSOP III included age,
gender, race, ethnicity, vital signs, level of conscious-
ness, Glasgow Coma Scale score, standardized time
intervals, and EMS provider impression. The core
RAMs and OMs are recommended to be used in
addition to these specific ones in out-of-hospital care
evaluation and research.
An example of how a measure could be applied
within the ‘‘episode of care’’ is shown in the out-of-
hospital outcomes model (Figure 2).2 Although there
have been some out-of-hospital clinical investigations
using pulse oximetry, PEFR, and VADS, their reliabil-
ity has not been studied in the out-of-hospital setting.
Therefore, it will be necessary to substantiate that
these measures are feasible and reliable when used to
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evaluate care rendered in the field. Particular atten-
tion should be paid to the impact of patient age on
feasibility. Age, for example, might alter a patient’s
ability to use a peak flow meter.
It is notable and encouraging that recent investiga-
tions conducted as part of the Ontario Prehospital
Advanced Life Support (OPALS) Study have linked
intermediate and distal outcomes to advanced life
support interventions performed in the field.10–12,65,66
These have included several RAMs and OMs related
to disability (functional measures) and discomfort.
These OMs have included the SF-36, the Cerebral
Performance Category, the Health Utility Index Mark
III, the Functional Independence Measure, and self-
reported symptom relief.8,65 The SF-36 has become
a widely utilized and adapted measurement tool. It is
a 36-item survey that was constructed to survey health
status in the Medical Outcomes Study.67 The OPALS
investigators published their methods of determining
costs in their out-of-hospital research.68,69 They have
reported cost–effectiveness in terms of dollars per life
saved70 and dollars per quality-adjusted life year.71
Because EMSOP evaluated the actual feasibility,
reliability, and validity of the RAMs and OMs related
to out-of-hospital care, the absence of prior studies
evaluating intermediate and long-term outcomes pre-
vent our recommending any of these measures. How-
ever, it is encouraging to see robust out-of-hospital
controlled clinical trials utilizing these measures. Un-
doubtedly these studies will add much to our knowl-
edge of the feasibility of their use in future EMS
outcomes research.
Capnometry and capnography are emerging tech-
nologies that may become valuable RAMs and OMs
in the out-of-hospital setting. Although their use is
increasing in intubated and nonintubated patients,
inadequate research was found to conclude that they
are valid and reliable in the out-of-hospital setting for
this purpose.72–78
This report underscores a number of important
research issues that need to be addressed: 1) the
feasibility and reliability of the PEFR and VADS in
the out-of-hospital setting and how these vary by
provider level; 2) the limits of the VADS in the
pediatric population; 3) the absence of any identified
OM for disability, satisfaction, or cost; and 4) a lack of
established association between these measures and
distal outcomes. For example, it is unknown whether
improvement in the oximetry values measured after
out-of-hospital interventions is related to outcomes
such as hospital admission rates, length of stay,
functional disability, and return to work.
LIMITATIONS
This study has several limitations. Only English-
language articles and AIM-listed journals were used
in the MEDLINE search. Thus, we cannot be abso-
lutely sure that we have identified all potentially
meaningful measures. We believed that the strategy,
which included full article and reference list review,
was the most effective to locate the influential pub-
lications for our structured review. In addition, our
methodology depends on the validity of the use of an
expert panel. Such methodologies always raise the
possibility of bias or other attributes that can com-
promise the validity of the recommendations.
CONCLUSIONS
We reviewed the literature pertaining to RAMs and
OMs relevant to respiratory distress. Using a previ-
ously published process, a structured review of stud-
ies, and consensus expert panel opinion, we
recommend utilization of the following measures,
along with core measures, as RAMs and OMs: pulse
oximetry, PEFR, and VADS. Furthermore, we recom-
mend mortality as an OM. The paucity of reliable,
validated RAMs and OMs for outcomes research in
the field, while not surprising, is disturbing. Major
efforts are needed in the future to promote the
development of validated tools for out-of-hospital
outcomes research.
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